These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 7775440

  • 1. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
    Saenko EL, Scandella D.
    J Biol Chem; 1995 Jun 09; 270(23):13826-33. PubMed ID: 7775440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
    Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D.
    Biochem J; 1992 Feb 15; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
    Saenko E, Sarafanov A, Greco N, Shima M, Loster K, Schwinn H, Josic D.
    J Chromatogr A; 1999 Aug 06; 852(1):59-71. PubMed ID: 10480230
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topography of the human factor VIII-von Willebrand factor complex.
    Fay PJ, Smudzin TM.
    J Biol Chem; 1990 Apr 15; 265(11):6197-202. PubMed ID: 2108154
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
    Nogami K, Shima M, Giddings JC, Takeyama M, Tanaka I, Yoshioka A.
    Int J Hematol; 2007 May 15; 85(4):317-22. PubMed ID: 17483075
    [Abstract] [Full Text] [Related]

  • 13. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O, Obert B, Meyer D, Girma JP.
    Blood; 1991 Nov 01; 78(9):2310-7. PubMed ID: 1834252
    [Abstract] [Full Text] [Related]

  • 14. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.
    Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS.
    J Biol Chem; 1987 Jun 25; 262(18):8443-6. PubMed ID: 3110147
    [Abstract] [Full Text] [Related]

  • 15. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA, Fulcher CA, Houghten RA, Zimmerman TS.
    Thromb Haemost; 1990 Jun 28; 63(3):403-6. PubMed ID: 2119526
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.